Skip to main content

Yon Su Kim

Seoul National University · Medicine

About the Lab

Professor Yon Su Kim's research lab focuses on immunology and nephrology, with a strong emphasis on the pathogenesis and treatment of kidney diseases. The lab investigates immune-mediated mechanisms in glomerular diseases such as membranous nephropathy and ischemia-reperfusion injury, particularly the roles of autoantibodies and natural killer T (NKT) cells. It also explores the clinical impact of metabolic acidosis in kidney transplant recipients and the immunological aspects of viral hemorrhagic fevers like HFRS. The lab integrates translational research with clinical studies to identify novel therapeutic targets and biomarkers in chronic kidney disease and renal transplantation.

nephrologyimmunomodulationautoantibodiesmetabolic acidosisviral nephropathy

Research Overview

Papers
635
Total Citations
14,095
Papers (5y)
80
Primary Field
Medicine

Research Output Trend

Figures are computed from collected data and may differ slightly.

Publications per year (5y)
80total
2022
2023
2024
2025
2026
Citations per year (5y)
1,051total
20222023202420252026

Selected Papers

15
1
Article|139 citations·2013
Autoantibodies against Phospholipase A2 Receptor in Korean Patients with Membranous Nephropathy
Yun Jung Oh, Seung Hee Yang, Dong Ki Kim, Shin‐Wook Kang, Yon Su Kim
SJR Q1FWCI 9.7PLoS ONEOA

American Society of Nephrology, October 30-November 04 2012, San Diego, CA, USA. Circulating autoantibodies against M-type phospholipase A 2 receptor (PLA 2 R) are important pathogenic antibodies of idiopathic membranous nephropathy (MN) in adults. However, previous studies on the clinical impact of anti-PLA 2 R antibodies demonstrated several limitations, including insufficient numbers of study subjects and different time points and methods for anti-PLA 2 R antibody measurement. To verify the c

NephrologyMedicine
2
Article|121 citations·1998
Targeting the IL-15 Receptor with an Antagonist IL-15 Mutant/Fcγ2a Protein Blocks Delayed-Type Hypersensitivity
Yon Su Kim, Włodzimierz Maśliński, Xin Xiao Zheng, A. Christopher Stevens, Li X, Greg H. Tesch, Vicki Rubin Kelley, Terry B. Strom
SJR Q1FWCI 2.8The Journal of ImmunologyOA

Owing to shared receptor components, the biologic activities of IL-15 are similar to those of IL-2. However, the patterns of tissue expression of IL-2/IL-2R alpha and IL-15/IL-15R alpha differ. The development of agents targeting the receptor and signaling elements of IL-15 may provide a new perspective for treatment of diseases associated with expression of IL-15/IL-15R. We designed, genetically constructed, and expressed a receptor site-specific IL-15 antagonist by mutating glutamine residues

ImmunologyImmunology and Microbiology
3
Article|105 citations·2010
Incidence and Outcomes of Contrast-Induced Nephropathy After Computed Tomography in Patients With CKD: A Quality Improvement Report
Sun Moon Kim, Ran‐hui Cha, Jung Pyo Lee, Dong Ki Kim, Kook‐Hwan Oh, Kwon Wook Joo, Chun Soo Lim, Suhnggwon Kim, Yon Su Kim
SJR Q1FWCI 5.6American Journal of Kidney Diseases
NephrologyMedicine
4
Article|89 citations·2016
A Randomized, Controlled Trial of Oral Intestinal Sorbent AST-120 on Renal Function Deterioration in Patients with Advanced Renal Dysfunction
Ran‐hui Cha, Shin‐Wook Kang, Cheol Whee Park, Dae Ryong, Ki Ryang Na, Sung Gyun Kim, Sun Ae Yoon, Sang Youb Han, Jae Hyun Chang, Sung Sup Park, Chun Soo Lim, Yon Su Kim
SJR Q1FWCI 7.6Clinical Journal of the American Society of NephrologyOA

Long-term use of AST-120 added to standard treatment did not change renal disease progression, proteinuria, mortality, and health-related quality of life in patients with advanced renal dysfunction.

PhysiologyMedicine
5
Article|89 citations·2011
Sulfatide-Reactive Natural Killer T Cells Abrogate Ischemia-Reperfusion Injury
Seung Hee Yang, Jung Pyo Lee, Hye Ryoun Jang, Ran‐hui Cha, Seung Seok Han, Un Sil Jeon, Dong Ki Kim, Junghan Song, Dong‐Sup Lee, Yon Su Kim
SJR Q1FWCI 2.6Journal of the American Society of NephrologyOA

There is a significant immune response to ischemia-reperfusion injury (IRI), but the role of immunomodulatory natural killer T (NKT) cell subtypes is not well understood. Here, we compared the severity of IRI in mice deficient in type I/II NKT cells (CD1d(-/-)) or type I NKT cells (Jα18(-/-)). The absence of NKT cells, especially type II NKT cells, accentuated the severity of renal injury, whereas repletion of NKT cells attenuated injury. Adoptively transferred NKT cells trafficked into the tubu

ImmunologyImmunology and Microbiology
6
Article|61 citations·2016
Metabolic Acidosis and Long-Term Clinical Outcomes in Kidney Transplant Recipients
Seokwoo Park, Eunjeong Kang, Sehoon Park, Yong Chul Kim, Seung Seok Han, Jongwon Ha, Dong Ki Kim, Sejoong Kim, Su-Kil Park, Duck Jong Han, Chun Soo Lim, Yon Su Kim
SJR Q1FWCI 4.6Journal of the American Society of NephrologyOA

Metabolic acidosis (MA), indicated by low serum total CO<sub>2</sub> (TCO<sub>2</sub>) concentration, is a risk factor for mortality and progressive renal dysfunction in CKD. However, the long-term effects of MA on kidney transplant recipients (KTRs) are unclear. We conducted a multicenter retrospective cohort study of 2318 adult KTRs, from January 1, 1997 to March 31, 2015, to evaluate the prevalence of MA and the relationships between TCO<sub>2</sub> concentration and clinical outcomes. The pr

NephrologyMedicine
7
Article|60 citations·2017
Midterm eGFR and Adverse Pregnancy Outcomes: The Clinical Significance of Gestational Hyperfiltration
Sehoon Park, Seung Mi Lee, Joong Shin Park, Joon‐Seok Hong, Ho Jun Chin, Ki Young Na, Dong Ki Kim, Kook‐Hwan Oh, Kwon Wook Joo, Yon Su Kim, Hajeong Lee
SJR Q1FWCI 3.1Clinical Journal of the American Society of NephrologyOA

We identified a unique U-shaped relationship between midterm eGFR and adverse pregnancy outcomes, and the optimal range of midterm eGFR levels was 120-150 ml/min per 1.73 m<sup>2</sup>. In those without evident functional renal impairment, the absence of prominent MRH might be a significant risk factor for poor pregnancy outcomes.

Obstetrics and GynecologyMedicine
8
Article|56 citations·2016
The Role of TNF Superfamily Member 13 in the Progression of IgA Nephropathy
Seung Seok Han, Seung Hee Yang, Murim Choi, Hang‐Rae Kim, Kwangsoo Kim, Sangmoon Lee, Kyung Chul Moon, Joo Young Kim, Hajeong Lee, Jung Pyo Lee, Ji Yong Jung, Sejoong Kim
SJR Q1FWCI 3.7Journal of the American Society of NephrologyOA

TNF superfamily member 13 (TNFSF13) has been identified as a susceptibility gene for IgA nephropathy in recent genetic studies. However, the role of TNFSF13 in the progression of IgA nephropathy remains unresolved. We evaluated two genetic polymorphisms (rs11552708 and rs3803800) and plasma levels of TNFSF13 in 637 patients with IgA nephropathy, and determined the risk of ESRD according to theses variable. Neither of the examined genetic polymorphisms associated with a clinical outcome of IgA ne

NephrologyMedicine
9
Article|52 citations·2013
Survival Advantage of Peritoneal Dialysis Relative to Hemodialysis in the Early Period of Incident Dialysis Patients: A Nationwide Prospective Propensity-Matched Study in Korea
Ji‐Young Choi, Hye Min Jang, Jongha Park, Yon Su Kim, Yon Su Kim, Shin‐Wook Kang, Chul Woo Yang, Nam‐Ho Kim, Jang-Hee Cho, Sunhee Park, Chan‐Duck Kim, Yong-Lim Kim
SJR Q1FWCI 1.6PLoS ONEOA

PD exhibits superior survival to HD in the early period of dialysis, even after adjusting for differences in the patients' characteristics between the two modalities. Notably, the most common cause of death was infection in this Korean cohort.

NephrologyMedicine
10
Article|49 citations·2016
Monitoring the Intracellular Tacrolimus Concentration in Kidney Transplant Recipients with Stable Graft Function
Seung Seok Han, Seung Hee Yang, Min Chang Kim, Joo‐Youn Cho, Sangil Min, Jung Pyo Lee, Dong Ki Kim, Jongwon Ha, Yon Su Kim
SJR Q1FWCI 2.7PLoS ONEOA

Although monitoring the intracellular concentration of immunosuppressive agents may be a promising approach to individualizing the therapy after organ transplantation, additional studies on this issue are needed prior to its clinical approval. We investigated the relationship between intracellular and whole blood concentrations of tacrolimus (IC-TAC and WB-TAC, respectively), the factors affecting this relationship, and the risk of rejection based upon IC-TAC in stable kidney recipients. Both IC

TransplantationMedicine
11
Article|46 citations·2001
Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression
Yon Su Kim, Daehee Kang, Do Yoon Kwon, Woong‐Yang Park, Ho Kim, Dong‐Sup Lee, Chun Soo Lim, Jin Suk Han, Suhnggwon Kim, Jung Sang Lee
FWCI 1.6Pharmacogenetics

Uteroglobin (UG) is an anti-inflammatory/immunomodulatory protein. Targeted disruption of UG rendered mouse glomerulonephritis resembling immunoglobulin (Ig)A nephropathy (IgAN). Sequence analysis on exon 1 of UG showed several putative binding sites for transcription factors, and polymorphisms in this site might influence the expression level of UG as a competitive protein. We speculated that the single nucleotide polymorphism at the 38th nucleotide (A to G) from the transcription initiation si

NephrologyMedicine
12
Article|45 citations·2012
Soluble Epoxide Hydrolase Activity Determines the Severity of Ischemia-Reperfusion Injury in Kidney
Jung Pyo Lee, Seung Hee Yang, Hee‐Yoon Lee, Bora Kim, Joo‐Youn Cho, Jin Ho Paik, Yun Jung Oh, Dong Ki Kim, Chun Soo Lim, Yon Su Kim
SJR Q1FWCI 1.9PLoS ONEOA

Soluble epoxide hydrolase (sEH) in endothelial cells determines the plasma concentrations of epoxyeicosatrienoic acids (EETs), which may act as vasoactive agents to control vascular tone. We hypothesized that the regulation of sEH activity may have a therapeutic value in preventing acute kidney injury by controlling the concentration of EETs. In this study, we therefore induced ischemia-reperfusion injury (IRI) in C57BL/6 mice and controlled sEH activity by intraperitoneal administration of the

BiochemistryBiochemistry, Genetics and Molecular Biology
13
Article|39 citations·2010
영아기 어머니의 언어적 반응성 및 영아의 비언어적 의사소통능력과 아동 초기 언어능력 간의 관계
김연수, 곽금주

본 연구는 영아기 어머니의 언어적 반응성 및 영아의 비언어적 의사소통능력이 이 시기 동안의 언어 뿐 아니라 아동 초기 언어능력과 어떤 관련성이 있는지를 알아보기 위해 62명의 아동을 대상으로 종단적으로 살펴보았다. 각 아동의 비언어적 의사소통 능력은 12개월에, 영아기 동안의 어휘는 12, 15, 18개월에, 아동 초기 언어능력은 42개월에 측정되었다. 12개월 당시 어머니의 언어적 반응성은 자유놀이 상황에서 어머니의 반응을, 12개월 영아의 비언어적 의사소통능력과 12, 15, 18, 42개월의 어휘는 각각 PICS(Pictorial Infant Communication Scale)와 어휘체크리스트(M-B CDI-K)와 아동발달검사(KCDI)로 측정되었다. 그 결과 12개월 당시 언어적 반응성은 12, 15개월의 어휘와 정적 상관이, 비언어적 의사소통능력은 12, 15, 18개월의 어휘 및 42개월의 언어능력과 정적 상관이 있었다. 한편 12개월 당시 어머니의 언어적 반응성은 42

14
Article|37 citations·2012
Pharmacokinetics of tacrolimus according to body composition in recipients of kidney transplants
Seung Seok Han, Do Hyoung Kim, Su Mi Lee, Nayoung Han, Jung Mi Oh, Jongwon Ha, Yon Su Kim
SJR Q1FWCI 0.2Kidney Research and Clinical PracticeOA

Taken together, these data suggest that tacrolimus dose monitoring based on body composition may provide adequate dosage leading to favorable long-term outcomes.

TransplantationMedicine
15
Article|34 citations·2012
Clinical outcomes of patients with hepatorenal syndrome after living donor liver transplantation
Jung Pyo Lee, Hyuk Yong Kwon, Ji In Park, Nam‐Joon Yi, Kyung‐Suk Suh, Hae Won Lee, Myoung‐Hee Kim, Yun Kyu Oh, Chun Soo Lim, Yon Su Kim
SJR Q1FWCI 1.8Liver Transplantation

Liver transplantation (LT) is the treatment of choice for hepatorenal syndrome (HRS). However, the clinical benefits of living donor liver transplantation (LDLT) are not yet well established. We, therefore, investigated the outcomes of patients with HRS who underwent LDLT and patients with HRS who received transplants from deceased donors. This study focused on 71 patients with HRS out of a total of 726 consecutive adult Korean patients who underwent LT at a single Asian center. We compared 48 p

HepatologyMedicine

Research Areas

NephrologyTransplantationImmunologyCardiology and Cardiovascular MedicineMolecular BiologySurgery

Dive deeper into Yon Su Kim's research on Nubint

Open this lab's papers in the app to read with AI, summarize, and cite in your writing.